Anti-Doping: Evidence to Policy
The McGill Institute for Health and Social Policy is organizing a panel on anti-doping policy that may be of interest to the Faculty of Law community.
Abstract
Anti-doping policy is the subject of an ongoing debate. It has played a significant role in efforts to curb doping over the past few decades. Yet among practitioners and scholars alike, very few argue decisively and with enthusiasm in its favour. The Institute for Health and Social Policy (IHSP) will host a discussion panel on how evidence can inform anti-doping policy.
The panel will bring together perspectives from a well-rounded group of researchers who will provide insight into their research on anti-doping policy.
Moderated by Daniel Weinstock, the presentations will address issues of public health ethics (Nicholas B. King), education and intervention among athletes (Lindsay Duncan), anti-doping ethics and gene doping (Erika Kleidermann), as well as current legal challenges for the international anti-doping framework (Bertrand Stoffel). Furthermore, Julien Sieveking, Director, Legal Affairs at the World Anti-Doping Agency will provide a first hand account on the ongoing revision of the World Anti-Doping Code.
Location:
McGill Institute for Health and Social Policy
Charles Meredith House, room 100
1130 Pine Avenue West
Montreal QCÂ H3A 1A3
